¹⁷⁷Lu-DOTA-HYNIC-Lys(Nal)-Urea-Glu: Biokinetics, Dosimetry, and Evaluation in Patients with Advanced Prostate Cancer

Figure 1

Schematic structure of the theranostic pair: (a) [^99mTc]Tc-EDDA/HYNIC-iPSMA ([^99mTc]Tc-iPSMA) and (b) ¹⁷⁷Lu-DOTA-HYNIC iPSMA (¹⁷⁷Lu-iPSMA). (c) Radio-HPLC analysis of ¹⁷⁷Lu-iPSMA obtained from a multidose lyophilized kit before injection to patients with high radiochemical purity (>99%).

(a)

(b)

(c)